Placebo News and Research

RSS

Oral contraceptive pills have negative impact on women's quality of life, study shows

One of the most common combined oral contraceptive pills has a negative impact on women's quality of life but does not increase depressive symptoms.

18 Apr 2017

Vitamin B supplements can mitigate impact of fine particle pollution on cardiovascular disease

B vitamins can mitigate the impact of fine particle pollution on cardiovascular disease, according to new research conducted at Columbia University's Mailman School of Public Health.

12 Apr 2017

FDA grants approval for first drug to treat adults with tardive dyskinesia

The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.

11 Apr 2017

Combination of NSAIDs and gastric protection can lead to inflammation in small intestine

Patients with inflammatory diseases are often prescribed non-steroidal anti-inflammatory drugs. They are also often recommended to use a proton pump inhibitor to protect their stomach.

11 Apr 2017

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Antipsychotic treatment can cause involuntary movements such as lip smacking, tongue protrusions and excessive eye blinking. These movements typically occur after more than 3 months of treatment and are called tardive dyskinesia.

7 Apr 2017

Patients with inducible urticaria can benefit from treatment with asthma drug

Patients who develop itchy wheals in response to cold or friction benefit from treatment with omalizumab, a drug normally used to treat asthma.

7 Apr 2017

Study highlights need for weight-appropriate dosing of healthy fat supplements

Body weight plays a significant role in how much benefit children may get from consuming "good" fats, new research suggests.

5 Apr 2017

Probiotics may help treat yeast infections, bowel problems in men with schizophrenia

In a small pilot study of men with schizophrenia, researchers at Johns Hopkins Medicine and Sheppard Pratt Health System say they have evidence that adding probiotics -- microorganisms, such as bacteria found in yogurts -- to the patients' diets may help treat yeast infections and ease bowel problems.

5 Apr 2017

Multivitamin use not linked to risk of major cardiovascular disease events

More than half of older American adults take a daily multivitamin supplement, but evidence of any clear health benefits is scarce.

5 Apr 2017

Study explores how to predict and prevent psychiatric morbidity in survivors of ARDS

After surviving acute respiratory distress syndrome, a disease in which fluid begins to leak into the lungs of critically ill patients and makes it difficult to breathe, many patients develop mental illness.

5 Apr 2017

MPA approves Renishaw study into chronic drug delivery system in Parkinson's patients

The Medicines Agency of Sweden, MPA, has authorised Herantis Pharma Plc and Renishaw plc’s randomised, placebo-controlled Phase 1-2 clinical study, for the investigation of Cerebral Dopamine Neurotrophic Factor (CDNF) and Renishaw’s chronic drug delivery system, in Parkinson’s patients.

4 Apr 2017

Study reveals potential new approach to treat posttraumatic stress disorder

A potential new approach to treat posttraumatic stress disorder: After taking the antibiotic doxycycline, study participants remembered an unpleasant event considerably less, as experiments conducted by a team of researchers from the University Psychiatric Hospital and the University of Zurich reveal.

4 Apr 2017

Common antibiotic can disrupt formation of negative associations in the brain, research reveals

The common antibiotic doxycycline can disrupt the formation of negative associations in the brain, according to new research from UCL and the University of Zurich.

4 Apr 2017

New drug compound could cut number of hot flushes in menopausal women

Women plagued by frequent hot flushes during the menopause could cut the number of flushes by almost three-quarters, thanks to a new drug compound.

3 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

University of Miami to begin clinical trial for testing DNA-based Zika vaccine

The University of Miami Miller School of Medicine will soon begin one of the nation's first full-scale Zika vaccine clinical trials testing the National Institutes of Health's (NIH) experimental DNA-based vaccine.

31 Mar 2017

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

Vaccinations have begun in a multi-site Phase 2/2b clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika infection.

31 Mar 2017

Balance test can temporarily alleviate common symptom in schizophrenia patients

A common symptom of schizophrenia - not knowing that you're ill -- can be temporarily alleviated using a balance test that stimulates part of the brain with cold water, an exploratory study at the Centre for Addiction and Mental Health has shown.

30 Mar 2017

Single dose of siRNA molecule offers protection against heart attack and stroke in high-risk patients

Even a single dose of a specific ribonucleic acid molecule, known as a small interfering RNA (siRNA), offers patients at high risk of cardiovascular disease long-lasting protection against high LDL cholesterol - one of the main risk factors for heart attack and stroke.

30 Mar 2017

Study examines effects of vitamin C doses on duration of common cold

The relationship between vitamin C dosage and its effects on the duration of the common cold symptoms may extend to 6-8 grams per day according to a statistical analysis published in Nutrients.

30 Mar 2017

Placebo News and Research

Oral contraceptive pills have negative impact on women's quality of life, study shows

Vitamin B supplements can mitigate impact of fine particle pollution on cardiovascular disease

FDA grants approval for first drug to treat adults with tardive dyskinesia

Combination of NSAIDs and gastric protection can lead to inflammation in small intestine

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Patients with inducible urticaria can benefit from treatment with asthma drug

Study highlights need for weight-appropriate dosing of healthy fat supplements

Probiotics may help treat yeast infections, bowel problems in men with schizophrenia

Multivitamin use not linked to risk of major cardiovascular disease events

Study explores how to predict and prevent psychiatric morbidity in survivors of ARDS

MPA approves Renishaw study into chronic drug delivery system in Parkinson's patients

Study reveals potential new approach to treat posttraumatic stress disorder

Common antibiotic can disrupt formation of negative associations in the brain, research reveals

New drug compound could cut number of hot flushes in menopausal women

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

University of Miami to begin clinical trial for testing DNA-based Zika vaccine

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

Balance test can temporarily alleviate common symptom in schizophrenia patients

Single dose of siRNA molecule offers protection against heart attack and stroke in high-risk patients

Study examines effects of vitamin C doses on duration of common cold

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News